These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25107927)

  • 1. Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment.
    Savige J
    J Physiol; 2014 Sep; 592(18):4013-23. PubMed ID: 25107927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
    Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
    Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
    Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
    PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of repairing glomerular basement membrane defects in Alport syndrome.
    Lin X; Suh JH; Go G; Miner JH
    J Am Soc Nephrol; 2014 Apr; 25(4):687-92. PubMed ID: 24262794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramipril therapy in integrin α1-null, autosomal recessive Alport mice triples lifespan: mechanistic clues from RNA-seq analysis.
    Madison J; Wilhelm K; Meehan DT; Gratton MA; Vosik D; Samuelson G; Ott M; Fascianella J; Nelson N; Cosgrove D
    J Pathol; 2024 Mar; 262(3):296-309. PubMed ID: 38129319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis.
    Delimont D; Dufek BM; Meehan DT; Zallocchi M; Gratton MA; Phillips G; Cosgrove D
    PLoS One; 2014; 9(6):e99083. PubMed ID: 24915008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alport Syndrome: Achieving Early Diagnosis and Treatment.
    Kashtan CE
    Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.
    Cosgrove D; Rodgers K; Meehan D; Miller C; Bovard K; Gilroy A; Gardner H; Kotelianski V; Gotwals P; Amatucci A; Kalluri R
    Am J Pathol; 2000 Nov; 157(5):1649-59. PubMed ID: 11073824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney Injury by Variants in the
    Frese J; Kettwig M; Zappel H; Hofer J; Gröne HJ; Nagel M; Sunder-Plassmann G; Kain R; Neuweiler J; Gross O
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage.
    Clark SD; Nabity MB; Cianciolo RE; Dufek B; Cosgrove D
    PLoS One; 2016; 11(12):e0168343. PubMed ID: 27959966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the pathomechanisms and future therapies of Alport syndrome.
    Noone D; Licht C
    Pediatr Nephrol; 2013 Jul; 28(7):1025-36. PubMed ID: 22903660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
    Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
    PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hematuria: A review.
    Plevová P; Gut J; Janda J
    Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.
    Hudson BG; Kalluri R; Gunwar S; Weber M; Ballester F; Hudson JK; Noelken ME; Sarras M; Richardson WR; Saus J
    Kidney Int; 1992 Jul; 42(1):179-87. PubMed ID: 1635348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
    Heidet L; Gubler MC
    Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity of a Human Laminin
    Funk SD; Bayer RH; Malone AF; McKee KK; Yurchenco PD; Miner JH
    J Am Soc Nephrol; 2018 Mar; 29(3):949-960. PubMed ID: 29263159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glomerular basement membrane as a barrier to albumin.
    Suh JH; Miner JH
    Nat Rev Nephrol; 2013 Aug; 9(8):470-7. PubMed ID: 23774818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α1β1 integrin/Rac1-dependent mesangial invasion of glomerular capillaries in Alport syndrome.
    Zallocchi M; Johnson BM; Meehan DT; Delimont D; Cosgrove D
    Am J Pathol; 2013 Oct; 183(4):1269-1280. PubMed ID: 23911822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.
    Kashtan CE
    Medicine (Baltimore); 1999 Sep; 78(5):338-60. PubMed ID: 10499074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.